Cardioimmunology Zurich

SEPTEMBER 14 – 16, 2022

Kartause Ittingen, Warth, SWITZERLAND

Congress

The meeting will highlight cutting-edge science from immunology and cardiology and provide insight into recent developments towards therapeutic targeting of cardiac inflammation.

?

Information

Activation and regulation of immune cells in the heart muscle and the pericardium are now recognized as key processes in cardiac diseases. Understanding and targeting the interaction of innate and adaptive immune cells with cardiomyocytes and cardiac stromal cells bears the potential to guide the development of future therapies for cardiomyopathy and heart failure patients. Cardioimmunology Zurich 2022 will highlight cutting-edge science from the fields of immunology and cardiology and provide insight into recent developments towards therapeutic targeting of cardiac inflammation.

 

Organizing committee

Pilar Alcaide

Pilar Alcaide

Kenneth and JoAnn G. Wellner Professor
Director, Immunology Graduate Program
Tufts University School of Medicine
Boston, USA
Gianluigi Condorelli

Gianluigi Condorelli

Director of Cardiovascular Research Area and Head of Lab
Director Department of Cardiovascular Medicine
Humanitas Research Hospital
Milan, Italy
Marinos Kallikourdis

Marinos Kallikourdis

Assistant Professor of Immunology and General Pathology,
Humanitas University
Group Leader, Adaptive Immunity Laboratory,
Humanitas Clinical and Research Center
Milan, Italy
Ludewig Burkhard

Burkhard Ludewig

Head Translational Cardioimmunology,
University Heart Center Zurich
Head Medical Research Center,
Cantonal Hospital St. Gallen
St. Gallen and Zurich, Switzerland
Frank Ruschitzka

Frank Ruschitzka

Head of the University Heart Center Zurich
Clinic Director Cardiology,
University Hospital Zurich
Zurich, Switzerland
Dorthe Schmidt

Dörthe Schmidt

Senior Physician Clinic for Cardiology
University Hospital Zurich
Zurich, Switzerland